{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T05:01:56Z","timestamp":1681448516393},"reference-count":0,"publisher":"Frontline Medical Communications, Inc.","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.12788\/jfp.0577","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T14:08:03Z","timestamp":1681394883000},"source":"Crossref","is-referenced-by-count":0,"title":["Should RAAS blockade therapy be continued in patients with advanced renal disease?"],"prefix":"10.12788","volume":"72","author":[{"given":"Kim","family":"Pham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5043","container-title":["The Journal of Family Practice"],"original-title":[],"link":[{"URL":"https:\/\/cdn.mdedge.com\/files\/s3fs-public\/JFP07204144.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T14:08:04Z","timestamp":1681394884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdedge.com\/familymedicine\/article\/262327\/mixed-topics\/should-raas-blockade-therapy-be-continued-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":0,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2023,4]]},"published-print":{"date-parts":[[2023,4]]}},"URL":"https:\/\/doi.org\/10.12788\/jfp.0577","relation":{},"subject":[],"published":{"date-parts":[[2023,4]]}}}